These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17482245)

  • 21. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum 17 alpha-hydroxyprogesterone in patients with gestational trophoblastic neoplasms.
    Osathanondh R; Goldstein DP; Tulchinsky D; Finn AE
    Obstet Gynecol; 1977 Jan; 49(1):77-9. PubMed ID: 187990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression pattern of beta human chorionic gonadotrophin in blood after chemotherapy for gestational trophoblastic neoplasia.
    Burrows A; Faddy MJ; Khoo SK
    Aust N Z J Obstet Gynaecol; 1996 Aug; 36(3):331-4. PubMed ID: 8883763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome.
    Ganapathy R; Lamont RF; Bassett P
    Prenat Diagn; 2007 Nov; 27(11):995-9. PubMed ID: 17621365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late spontaneous resolution of persistent molar pregnancy.
    Taylor F; Short D; Harvey R; Winter MC; Tidy J; Hancock BW; Savage PM; Sarwar N; Seckl MJ; Coleman RE
    BJOG; 2016 Jun; 123(7):1175-81. PubMed ID: 26774079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor.
    Bakri Y; al-Hawashim N; Berkowitz R
    J Reprod Med; 2000 Feb; 45(2):94-6. PubMed ID: 10710737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia.
    Rodriguez GC; Hughes CL; Soper JT; Berchuck A; Clarke-Pearson DL; Hammond CB
    Obstet Gynecol; 1994 Nov; 84(5):794-7. PubMed ID: 7936514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
    Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
    J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment.
    Yang J; Xiang Y; Wan X; Yang X
    Gynecol Oncol; 2006 Nov; 103(2):479-82. PubMed ID: 16631244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: morphologic and immunohistochemical features to resolve a diagnostic dilemma.
    Lewin SN; Aghajanian C; Moreira AL; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1809-14. PubMed ID: 19773636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies.
    Fisher RA; Savage PM; MacDermott C; Hook J; Sebire NJ; Lindsay I; Seckl MJ
    Gynecol Oncol; 2007 Dec; 107(3):413-9. PubMed ID: 17942145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
    Schneider DT; Calaminus G; Göbel U
    Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.